UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000010088
Receipt No. R000011817
Scientific Title Phase II study of Gemcitabine plus alternate-day administrations of S-1 in patients with unresectable advanced pancreatic cancer.
Date of disclosure of the study information 2013/02/21
Last modified on 2013/02/21 09:27:56

No. Disposal Last modified on Item of update
1 Insert 2013/02/21 09:30:12


Contact us.